Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hogy Medical Co ( (JP:3593) ) just unveiled an update.
Hogy Medical Co., Ltd. has issued an amendment to its prior notice supporting a tender offer for its shares by TCG2509 Co., Ltd., correcting the disclosed number of shares managed by major shareholder Grantham, Mayo, Van Otterloo & Co. LLC (GMO). The revision increases GMO’s tendered share count from 2,237,900 shares (10.38% ownership) to 2,256,100 shares (10.46% ownership), and an amended tender agreement has been executed to reflect this higher stake, reinforcing the feasibility of the tender offer and subsequent squeeze-out procedures, as well as GMO’s planned indirect acquisition of up to 5% economic interests in a Carlyle-managed fund via Cayman Islands limited partnership interests.
The most recent analyst rating on (JP:3593) stock is a Hold with a Yen5957.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.
More about Hogy Medical Co
Hogy Medical Co., Ltd. is a Japan-based medical products company listed on the Tokyo Stock Exchange Prime Market under securities code 3593. The company operates in the healthcare sector, focusing on medical supplies and related solutions for hospitals and clinical institutions, serving both domestic and potentially international markets.
Average Trading Volume: 195,467
Technical Sentiment Signal: Buy
Current Market Cap: Yen144B
Find detailed analytics on 3593 stock on TipRanks’ Stock Analysis page.

